38 filings
10-Q
2019 Q3
CNSP
Cns Pharmaceuticals Inc
20 Dec 19
Quarterly report
4:02pm
8-K
CNSP
Cns Pharmaceuticals Inc
22 Nov 19
CNS Pharmaceuticals Announces Full Exercise of Over-Allotment Option
8:00am
8-K
CNSP
Cns Pharmaceuticals Inc
14 Nov 19
CNS Pharmaceuticals Announces Closing Of Initial Public Offering of Common Stock
12:00am
4
CNSP
Cns Pharmaceuticals Inc
13 Nov 19
CNS Pharmaceuticals / Christopher Downs ownership change
5:12pm
3
CNSP
Cns Pharmaceuticals Inc
13 Nov 19
CNS Pharmaceuticals / Christopher Downs ownership change
5:11pm
3
ceqs8x3
8 Nov 19
CNS Pharmaceuticals / Waldemar Priebe ownership change
5:31pm
3
xhwz3
8 Nov 19
CNS Pharmaceuticals / Jeffry R. Keyes ownership change
5:31pm
3
ar3hhl6w76
8 Nov 19
CNS Pharmaceuticals / Jerzy Gumulka ownership change
5:30pm
3
0bvmsktnc 2rs5jd0xv
8 Nov 19
CNS Pharmaceuticals / Carl Anthony Evans ownership change
5:26pm
3
sqh0a0w co4w
8 Nov 19
CNS Pharmaceuticals / John M Climaco ownership change
5:25pm
3
4m81iosuqrtxvsz3
8 Nov 19
CNS Pharmaceuticals / Andrzej Andraczke ownership change
5:24pm
424B4
wpmbfbsnokhutlp
8 Nov 19
Prospectus supplement with pricing info
4:25pm
EFFECT
i9ks 32p4j8vfbi
8 Nov 19
Notice of effectiveness
12:15am
CERT
11e1 8cncv6
6 Nov 19
Certification of approval for exchange listing
10:38am
8-A12B
s2jehwm1rz1f8gtuqxpv
5 Nov 19
Registration of securities on exchange
12:15pm
CORRESP
pza0shimzvytcsjh4qfj
5 Nov 19
Correspondence with SEC
12:00am
CORRESP
rga8ogoea2 grsc
5 Nov 19
Correspondence with SEC
12:00am
FWP
shnvgc2secb0w4gk
11 Oct 19
Free writing prospectus
9:05pm
FWP
zuk2h
10 Oct 19
Free writing prospectus
2:26pm